GYRE THERAPEUTICS, INC. ($GYRE)
Filing Information
| Accession Number | 0001140361-26-022642 |
|---|---|
| Form Type | 4 |
| Filing Date | May 22, 2026 |
| Document | View SEC Filing |
Transactions
6
Total Shares
66,660
Total Value
$153,318.00
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Operating Officer | Common Stock | โ | May 20, 2026 | Exercise/Conversion | 9,400 | $0.75 | $7,050.00 | 709,400 | Direct | โ | View Details | |
Chief Operating Officer | Common Stock | โ | May 20, 2026 | Sale | 9,400 | $6.15 | $57,810.00 | 700,000 | Direct | โ | View Details | |
Chief Operating Officer | Common Stock | โ | May 21, 2026 | Exercise/Conversion | 12,820 | $0.75 | $9,615.00 | 712,820 | Direct | โ | View Details | |
Chief Operating Officer | Common Stock | โ | May 21, 2026 | Sale | 12,820 | $6.15 | $78,843.00 | 700,000 | Direct | โ | View Details | |
Chief Operating Officer | Stock Option (Right to Buy) | Derivative | May 20, 2026 | Exercise/Conversion | 9,400 | $0.00 | $0.00 | 917,715 | Direct | โ | View Details | |
Chief Operating Officer | Stock Option (Right to Buy) | Derivative | May 21, 2026 | Exercise/Conversion | 12,820 | $0.00 | $0.00 | 904,895 | Direct | โ | View Details |